We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Gilead Sciences recently announced that it would no longer pursue FDA approval for Jyseleca and it downgraded a multibillion-dollar development pact with Galapagos. Read More
Cabenuva, the first long-acting injectable drug for HIV, has received FDA approval, providing the first-ever FDA-approved alternative to oral meds taken every day by those living with HIV. Read More
The CAR-T therapy uses the patient’s white blood cells as modified in a laboratory to attack cancer cells before being infused back into the patient. Read More
The approval was based on positive results from a phase 2 trial that showed Enhertu led to improvement in overall survival and response rate vs. chemotherapy. Read More
Roche said the approval “marks the first innovation in mechanism of action for an influenza antiviral” approved by the European Commission in almost 20 years. Read More
The drug was first approved in 2014 for treating type 2 diabetes and for reducing the risk of cardiovascular death in patients with type 2 diabetes. Read More